ThermoGenesis Announces Management Transition; Provides Update on Operational ...(iscal year 2009 and introduction of comp...),Health

Date:12/3/2008

iscal year 2009, and introduction of competitive products and other factors beyond our control, could result in a materially different revenue outcome and/or in our failure to achieve the revenue levels we expect for fiscal 2009. A more complete description of these and other risks that could cause actual events to differ from the outcomes predicted by our forward-looking statements is set forth under the caption "Risk Factors" in our annual report on Form 10-K and other reports we file with the Securities and Exchange Commission from time to time, and you should consider each of those factors when evaluating the forward-looking statements.

     ThermoGenesis Corp.
     Web site:http://www.thermogenesis.com
     Contact: Investor Relations
     +1-916-858-5107, or
     ir@thermogenesis.com

'/>"/>

SOURCE ThermoGenesis Corp. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related medicine news :

1. ThermoGenesis Reports First Quarter 2009 Results
2. ThermoGenesis Announces 10 New BioArchive(R) System Distributors
3. ThermoGenesis Announces Filing of 510(k) Application for MarrowXpress
4. Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine
5. ThermoGenesis Corp. Reports First Quarter 2008 Results
6. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
7. Integrated Benefits Institute Announces Availability of 2007 IBI Benchmarking Data for Employers to Evaluate Effectiveness of their Health and Productivity Programs
8. Vertellus Specialties Announces Price Change
9. HLTH Corporation Announces Final Results of Its Tender Offer
10. Hill-Rom Announces First Quarter 2009 Dividend
11. Writing a Prescription for Safety: B. Braun CAPS(R) Announces New Advancements at ashp 2008